When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SYBX - Homology Medicines on go with study of gene therapy for PKU
Synlogic Inc.
The FDA has signed off on a Phase 1/2 clinical trial, pheNIX, evaluating Homology Medicines' (FIXX+0.4%) gene therapy candidate HMI-102 in adults with a rare inherited disorder called phenylketonuria (PKU), referred to as an inborn error of metabolism.
More news on: Homology Medicines, Inc., BioMarin Pharmaceutical Inc., Codexis, Inc., Healthcare stocks news, Stocks on the move,